Effect of preventive analgesia by injection of a local anesthetic before vaginal incision for hysterectomy by the vNOTES approach: a randomized double-blind study ANOTES study

2023-504926-20-00 Protocol 2022/0270/HP Therapeutic confirmatory (Phase III) Ongoing, recruiting

Start 19 Apr 2024 · Status Ongoing, recruiting · 1 EU/EEA countries · 2 sites · Protocol 2022/0270/HP

Overview

Sponsor-declared trial summary

Phase Therapeutic confirmatory (Phase III)
Status Ongoing, recruiting
Participants planned 108
Countries 1
Sites 2

Hysterectomy

Key facts

Sponsor
CHU De Rouen
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Female
Therapeutic area
Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]
Trial duration
19 Apr 2024 → ongoing
Decision date (initial)
2023-10-24
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

External identifiers

EU CT number
2023-504926-20-00
ClinicalTrials.gov
NCT05969457

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Hysterectomy

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

CHU De Rouen

3 Total trials 2 Recruiting
Academic / Non-commercial
Sponsor organisation
CHU De Rouen
Address
1 Rue De Germont, Bp 96031 Bp 96031
City
Rouen Cedex
Postcode
76031
Country
France

Scientific contact point

Organisation
CHU De Rouen
Contact name
Patrice CROCHET

Public contact point

Organisation
CHU De Rouen
Contact name
David Mallet

Locations

1 EU/EEA country · 2 investigational sites

By country

CountryMS statusPlanned subjectsSites
France Ongoing, recruiting 108 2
Rest of world 0

Investigational sites

France

2 sites · Ongoing, recruiting
CHU De Rouen
gynecologic-obstetrical department, 1 Rue De Germont, Bp 96031, Rouen Cedex
Groupe Hospitalier Du Havre
gynecologic-obstetrical department, 55 B Rue Gustave Flaubert, Bp 24, Le Havre Cedex

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
France 2024-04-19 2025-09-16

Application history

5 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2023-07-18 France Acceptable
2023-10-23
2023-10-24
2 SUBSTANTIAL MODIFICATION SM-1 2024-06-14 France Acceptable
2024-07-08
2024-07-30
3 NON SUBSTANTIAL MODIFICATION NSM-1 2025-04-07 France Acceptable
2024-07-08
2025-04-07
4 SUBSTANTIAL MODIFICATION SM-2 2025-05-16 France Acceptable
2025-06-25
2025-06-26
5 SUBSTANTIAL MODIFICATION SM-3 2026-01-13 France Acceptable
2026-03-02
2026-03-27